Clinical Trials Logo

Congenital Deafness clinical trials

View clinical trials related to Congenital Deafness.

Filter by:
  • None
  • Page 1

NCT ID: NCT06370351 Not yet recruiting - Clinical trials for Hearing Loss, Sensorineural

A Phase I/II Clinical Trial With SENS-501 in Children Suffering From Severe to Profound Hearing Loss Due to Otoferlin (OTOF) Mutations

AUDIOGENE
Start date: April 30, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

This study intends to assess safety, tolerability, and efficacy of SENS-501 in children between the ages of 6-31 months with pre-lingual hearing loss due to a mutation in the Otoferlin gene.

NCT ID: NCT06365749 Not yet recruiting - Congenital Deafness Clinical Trials

Genetic Feature of Congenital Hearing Loss in Chinese Population

Start date: April 23, 2024
Phase:
Study type: Observational

Congenital hearing loss, as well as hearing loss present at birth, is one of the most common chronic conditions in children, with a prevalence of permanent bilateral hearing loss of 2.83 per 1000 children of primary school age, which is mainly caused by genetic factors. The goal of this observational study is to learn about novel causative genes in infants with hearing loss in the Chinese population. The main problem it aims to deal with are: - to present the genetic characteristics of the infant with hearing loss in the Chinese population - to build up a prognostic model base on diverse data. Participants will be asked to receive audiological tests and collection of the peripheral blood sample.

NCT ID: NCT05402813 Recruiting - Clinical trials for Sensorineural Hearing Loss, Bilateral

Natural History in Children up to 10 Years With Moderate to Profound Hearing Loss Due to Mutations in GJB2 / OTOF Genes

Otoconex
Start date: November 18, 2022
Phase:
Study type: Observational

The purpose of this study is to follow the natural history of non-syndromic hearing loss caused by mutations in two genes (GJB2 or OTOF) in children up to 10 years of age.

NCT ID: NCT04350619 Not yet recruiting - Congenital Deafness Clinical Trials

NGS Assessment of Congenitally Deafned Children and Neonatal Deafness Screnning

GHELP
Start date: April 30, 2020
Phase:
Study type: Observational

To assess the diagnostic value of NGS screnning in prelingually deafned children using a new designed chip, and to evaluate its interest in a the neonatal screening program for ddetecting congenitally deafned children.

NCT ID: NCT03866850 Terminated - Congenital Deafness Clinical Trials

Degenerative Consequences of Congenital Deafness

Start date: August 1, 2019
Phase:
Study type: Observational

In this study, the investigators will study one of the basic biophysical properties of the auditory nerve, charge integration, behaviorally (detection threshold versus phase duration functions). The investigators will compare charge integration in two subject groups: congenitally deafened and deafened at a later age in life. The investigators will then examine if behaviorally estimated neural excitation patterns differ between short phase duration and long phase duration stimulation. Lastly, The investigators will measure if speech recognition improves with using long phase duration stimulation, relative to using the standard default short phase duration stimulation. The primary endpoint of the study is speech recognition, and the secondary endpoints are the steepness of the detection threshold versus phase duration functions, and the width of psychophysically estimated neural excitation.

NCT ID: NCT03319524 Completed - Clinical trials for Retinitis Pigmentosa

Clinical and Genetic Testing of Patients With Usher Syndrome

Start date: May 17, 2017
Phase:
Study type: Observational [Patient Registry]

This study is aimed to characterize Russian population of Usher patients.

NCT ID: NCT00400413 Completed - Congenital Deafness Clinical Trials

Neuroanatomy of Reading in Congenital Deafness.

Start date: November 2003
Phase: N/A
Study type: Interventional

The aim of the research is to investigate phonological processing in deafness and to examine its influence on the neuroanatomy of reading.The basic hypothesis is that insofar as the ability to read is closely related to the ability to segment and represent speech units, the neuroanatomy of reading in deaf would be different from the one of hearing readers.

NCT ID: NCT00106743 Completed - Clinical trials for Retinitis Pigmentosa

Natural History and Genetic Studies of Usher Syndrome

Start date: March 21, 2005
Phase:
Study type: Observational

This study will explore clinical and genetic aspects of Usher syndrome, an inherited disease causing deafness or impaired hearing, visual problems, and, in some cases, unsteadiness or balance problems. Patients with type 1 Usher syndrome usually are deaf from birth and have speech and balance problems. Patients with type 2 disease generally are hearing impaired but have no balance problems. Patients with type 3 disease have progressive hearing loss and balance problems. All patients develop retinitis pigmentosa, an eye disease that causes poor night vision and eventually, blindness. Patients of any age with Usher syndrome may be eligible for this study. Patients who have had eye and hearing evaluations are asked to send their medical records to the research team at the National Eye Institute (NEI) for review. They are also asked to have a blood sample drawn by a medical professional and sent to NEI for genetic analysis. Finally, they are interviewed about their family histories, particularly about other relative with eye disease. Patients who have not been evaluated previously have the following tests and procedures at NIH: - Family medical history, especially regarding eye disease. A family tree is drawn. - Blood draw for genetic studies of Usher syndrome. - Eye examination to assess visual acuity and eye pressure, and to examine pupils, lens, retina, and eye movements. - Electroretinogram (ERG) to test the function of visual cells. Wearing eye patches, the patient sits in a dark room for 30 minutes. Electrodes are taped to the forehead and the eye patches are removed. The surface of the eye is numbed with eye drops and contact lenses are placed on the eyes. The patient looks inside a hollow, dark globe and sees a series of light flashes. Then a light is turned on inside the globe and more flashes appear. The contact lenses sense small electrical signals generated by the retina when the light flashes. - Fluorescein angiography to evaluate the eye's blood vessels. A yellow dye is injected into an arm vein and travels to the blood vessels in the eyes. Pictures of the retina are taken using a camera that flashes a blue light into the eye. The pictures show if any dye has leaked from the vessels into the retina, indicating possible blood vessel abnormality. - Hearing tests to help determine the patient's type of Usher syndrome. Tests to evaluate hearing include examination of both ears with an otoscope, evaluation of the middle ear and inner ear, and hearing tests using earphones that deliver tones and words the subject listens and responds to. - Vestibular testing for balance function. Balance testing involves three procedures: Videonystagmography: This test records eye movements with little cameras. First the patient follows the movements of some small lights. Next, while wearing goggles, the patient lies on an exam table and turns to the right and left. Lastly, a soft stream of air is blown into the patient's ears four times, once in each ear with cool air and once in each ear with warm air. Rotary chair test: With electrodes placed on the forehead, the patient sits in a rotary chair in a dark room. Several red lights appear on the wall of the room and the patient follows the lights as they move back and forth. Then the chair turns at several speeds, all slower than a merry-go-round. Vestibular evoked potential: Electrodes are placed behind the patient's ear and at the base of the neck. Seated in a reclining chair and wearing earphones, the patient hears a brief series of loud clicking sounds. When the sounds are on, the patient is asked to lift his or her head up a few inches from the chair. The electrodes record information from the muscles in the neck as the sounds enter the ear.